Promoted Content Promoted Content

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Loading...

All Data

Filters Filter
×
FILTER:
filter News Type
    filter Company
      filter Product Type
        filter Deal Size
          filter Upfront Payment

            Active Filter(s):

            Product Type

            Companies

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Lead Product(s): IMB-150

            Therapeutic Area: Urology Product Name: LYT-503

            Highest Development Status: Preclinical Product Type: Large molecule

            Partner/Sponsor/Collaborator: Imbrium Therapeutics

            Deal Size: $59.5 million Upfront Cash: Undisclosed

            Deal Type: Licensing Agreement August 11, 2021

            Details:

            Under the terms of the agreement, Imbrium is responsible for all future development activities and funding for LYT-503/IMB-150, for which an IND filing is planned for early 2022.